Aspira Women's Health Inc., a company known for its development and commercialization of diagnostic tests for gynecologic disease, is making waves in the United States' healthcare industry. The company's portfolio of products includes Ova1, a blood test intended for assessing the likelihood of malignancy in women with an ovarian adnexal mass, as well as Overa, a biomarker reflex test, and Ova1Plus, a reflex offering. Aspira Women's Health Inc. is also working on OvaWatch, a non-invasive blood-based risk assessment test that helps determine ovarian cancer risk for patients with an adnexal mass, and Endocheck, an in-development non-invasive blood test designed as an aid in the identification of endometriosis for patients with suspected endometriosis earlier in their prognosis journey. Alongside its product offerings, Aspira Women's Health Inc. runs Aspira Synergy, a testing platform and cloud service, and ASPiRA LABS, a specialized lab that applies biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. The company serves physicians, physician office laboratories, and national and regional laboratories and distributes its products through its national sales force, its platform Aspira Synergy, and a marketing and distribution agreement with BioReference Health, LLC. In addition to their existing portfolio, Aspira Women's Health Inc. has a research agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies to develop an early detection test for ovarian cancer. They also have a strategic alliance with Quest Diagnostics, Incorporated. Aspira Women's Health Inc. was incorporated in 1993 and is based in Austin, Texas. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020, marking a significant milestone in its journey to offer innovative diagnostic solutions for women's health across the United States.
Aspira Women's Health's ticker is AWH
The company's shares trade on the NASDAQ stock exchange
They are based in Austin, Texas
There are 51-200 employees working at Aspira Women's Health
It is aspirawh.com
Aspira Women's Health is in the Healthcare sector